Virtus Fund Advisers’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RG
BI
RCMNY
PA
Virtus Fund Advisers's ZYME Position: Q4 2024 in Review
Virtus Fund Advisers sold out of Zymeworks (ZYME) in Q4 2024, closing a stake of 1,908 shares — an estimated $23.9K sold.
Virtus Fund Advisers first reported a position in ZYME in Q4 2023 and held it in 4 quarters. The position peaked at $32.6K in Q1 2024. 172 funds tracked by Wall St. Rank hold ZYME as of Q4 2024.
- Virtus Fund Advisers reported no remaining Zymeworks position as of Q4 2024 after selling out during the quarter.
- Virtus Fund Advisers sold 1,908 Zymeworks shares in Q4 2024, an estimated $23.9K.
- Virtus Fund Advisers first reported a position in Zymeworks in Q4 2023 and held it in 4 quarters.
- Virtus Fund Advisers's Zymeworks position peaked at $32.6K in Q1 2024.
- 172 funds tracked by Wall St. Rank held Zymeworks as of Q4 2024.
Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.